ARTICLE | Clinical News
MoxDuo IR: Phase II/III data
August 31, 2009 7:00 AM UTC
QRxPharma Ltd. (ASX:QRX), Brisbane, Australia Product: MoxDuo IR ( Q8003IR) Business: Neurology Molecular target: NA Description: Immediate-release combination of oxycodone and morphine Indication: T...